Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Boundless Bio, Inc. (BOLD) had Tangible Shareholders Equity of $98.65M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-12.88M |
|
-- |
|
-- |
|
$14.00M |
|
$-14.00M |
|
$1.12M |
|
$-12.88M |
|
$-12.88M |
|
$-12.88M |
|
$-12.88M |
|
$-12.88M |
|
$-12.88M |
|
$-14.00M |
|
$-13.70M |
|
22.36M |
|
22.36M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$109.61M |
|
$3.22M |
|
$47.45M |
|
$157.06M |
|
$12.54M |
|
$45.87M |
|
$45.87M |
|
$58.41M |
|
$98.65M |
|
|
Tangible Shareholders Equity |
$98.65M |
$98.65M |
|
22.41M |
|
| Cash Flow Statement Financials | |
$-46.66M |
|
$37.80M |
|
$0.14M |
|
$27.15M |
|
$18.43M |
|
$-8.72M |
|
$6.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.74 |
|
-- |
|
-- |
|
0.32 |
|
0.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.06% |
|
-13.06% |
|
-8.20% |
|
-8.92% |
|
$4.40 |
|
$-2.11 |
|
$-2.09 |
|